Clinical trial
Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor…
NCT00067821 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00067821 |
|---|---|
| Title | Comparison of PET and Proton MRS Imaging to Evaluate Pediatric Brain Tumor Activity |
| Official title | A Comparative Study of Pediatric CNS Tumor Activity as Assessed by 18F-FDG PET Imaging and Proton Magnetic Resonance Spectroscopic Imaging (1H-MRSI) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Brain Tumors |
| Intervention type | Drug |
| Interventions | 2-Flourodeoxyglucose |
| Enrollment | 79 |
| Start date | Feb 11, 2014 |
| Primary completion | May 10, 2019 |
| Completion | May 10, 2019 |
| First posted | Aug 28, 2003 |
| Last update posted | Jun 13, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: